Environmental Risk Study on CH3NO2

被引：0
作者：
Zhou, Jihong
Chen, Weixia
机构：
来源：
MATERIALS SCIENCE AND ENGINEERING, PTS 1-2 | 2011年 / 179-180卷
关键词：
CH3NO2; environmental risk characteristics; preventive measures;
D O I：
10.4028/www.scientific.net/AMR.179-180.865
中图分类号：
T [工业技术];
学科分类号：
08 ;
摘要：
Environmental risk study is very important because of existence of chemical substance that probably leads to a lot of harm. At present, the environmental risk has become science foundation and one of important basics of the environmental risk management and environmental decision-making. This paper based on the chemical properties of nitromethane including physical and chemical properties, toxicity, explosive harms characteristics are studied and puts forward some preventive measures.
引用
收藏
页码：865 / 868
页数：4
相关论文
共 33 条
  • [21] Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents-A retrospective study of 240 patients
    Coropciuc, Ruxandra
    Coopman, Renaat
    Garip, Melisa
    Gielen, Evelien
    Politis, Constantinus
    Van den Wyngaert, Tim
    Beuselinck, Benoit
    BONE, 2023, 170
  • [22] Long-term outcomes of prolonged bisphosphonates more than 2 years in bone metastatic breast cancer: risk vs benefit
    Bal, Oznur
    Oksuzoglu, Berna
    Dogan, Mutlu
    Durnali, Ayse
    Uyeturk, Ummugul
    Demirci, Ayse
    Arslan, Ulku Yalcintas
    Ekinci, Ahmet Siyar
    Yildirim, Nuriye
    Alkis, Necati
    Kilic, Selim
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (03) : 805 - 810
  • [23] A 5-year retrospective longitudinal study on the incidence and the risk factors of osteonecrosis of the jaws in patients treated with zoledronic acid for bone metastases from solid tumors
    Manfredi, Maddalena
    Mergoni, Giovanni
    Goldoni, Matteo
    Salvagni, Stefania
    Merigo, Elisabetta
    Meleti, Marco
    Vescovi, Paolo
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2017, 22 (03): : E342 - E348
  • [24] Relationship Between Psychological Responses and the Appraisal of Risk Communication During the Early Phase of the COVID-19 Pandemic: A Two-Wave Study of Community Residents in China
    Jin, Zheng
    Zhao, Kai-bin
    Xia, Yan-yu
    Chen, Rui-jun
    Yu, Huan
    Tamunang Tamutana, Timothy
    Yuan, Zheng
    Shi, Yi-Ming
    Adamseged, Hanna Yeshinegus
    Kogay, Marina
    Park, Gyun Yeol
    FRONTIERS IN PUBLIC HEALTH, 2020, 8
  • [25] Prospective Pilot Study Evaluating SARS-CoV-2 Transmission-Limiting Measures in an On-Site School
    Jani, Shilpa G.
    Ma, Jasmin
    Pulendran, Uma
    Hsing, Julianna C.
    Altamirano, Jonathan
    Shah, Soleil
    Toomarian, Elizabeth Y.
    Maldonado, Yvonne
    Wang, Chih-Hung Jason
    ACADEMIC PEDIATRICS, 2022, 22 (04) : 671 - 679
  • [26] Protective barrier properties of Rhinosectan® spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study
    Barbara De Servi
    Francesco Ranzini
    Núria Piqué
    Allergy, Asthma & Clinical Immunology, 13
  • [27] Protective barrier properties of Rhinosectan® spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study
    De Servi, Barbara
    Ranzini, Francesco
    Pique, Nuria
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2017, 13 : 1 - 8
  • [28] Seroprevalence of SARS-CoV-2 Infection and Adherence to Preventive Measures in Cuenca, Ecuador, October 2020, a Cross-Sectional Study
    Acurio-Paez, David
    Vega, Bernardo
    Orellana, Daniel
    Charry, Ricardo
    Gomez, Andrea
    Obimpeh, Michael
    Verhoeven, Veronique
    Colebunders, Robert
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (09)
  • [29] Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial
    Sibylle Kautz-Freimuth
    Marcus Redaèlli
    Anna Isselhard
    Arim Shukri
    Andrea Vodermaier
    Kerstin Rhiem
    Rita Schmutzler
    Stephanie Stock
    Trials, 23
  • [30] Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial
    Kautz-Freimuth, Sibylle
    Redaelli, Marcus
    Isselhard, Anna
    Shukri, Arim
    Vodermaier, Andrea
    Rhiem, Kerstin
    Schmutzler, Rita
    Stock, Stephanie
    TRIALS, 2022, 23 (01)
1234